Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells. - Test2 - elhamkhani - TriplyDB

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

http://www.wikidata.org/entity/Q37202568

about

Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis Loss of PPARγ in endothelial cells leads to impaired angiogenesis.The TCR γδ repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vδ1 and Vδ2 T cells.Alteration of gene expression profile following PPP2R5C knockdown may be associated with proliferation suppression and increased apoptosis of K562 cells.Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia.

P2860

Q34492636-B3E9BF0F-1E12-4915-97F8-F12FCEAD59E0 Q34978247-D7E761E8-6D0A-4F42-98B0-86F362FE8220 Q35110756-391566F2-0B57-47F9-BFB1-59803744C6B9 Q35817508-0A524F13-8856-4B12-B200-E09A3768CC75 Q37413074-D2067F95-6F26-4A4E-8F24-3CF271BD9B84 Q37433992-2B13695D-7652-4A50-826A-46946E404F05 Q42581908-19734C43-B4A4-478D-A04B-799C3B82C7C0 Q44561492-1280D8B9-907F-49F6-8114-EBB37846C9BF

P2860

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

http://www.wikidata.org/entity/Q37202568

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

@en

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

@nl

type

label

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

@en

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

@nl

prefLabel

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

@en

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

@nl

P1433

Q37202568-391A8339-B121-4B65-ADBD-BA0EFF77C8FD

P1476

Q37202568-D3357098-A2D4-4CBA-8005-14BF0579DD87

P2093

Q37202568-475F9DD2-67D7-49FA-BD9D-B3DD9E475E22

Q37202568-478DD33B-164D-450C-AB83-6AC2EB3A9287

Q37202568-4C8EFF86-A545-42EA-89DB-38B888E21354

Q37202568-502C88CD-9951-4D61-9735-0FD7398A147B

Q37202568-5C24DEA0-D8CB-4112-80CC-E8855340C6F5

Q37202568-75C5C6FE-BC7B-4C1C-9260-08581073ACC0

Q37202568-78E7C48E-0D92-4F3D-B9B3-6DA242319340

Q37202568-7D0EAE0A-F5B7-4C25-B6AB-2CD1E50B2E34

Q37202568-D76C045E-CEE0-4218-BD28-6172CD03B246

Q37202568-ED1F4D30-5D88-43B2-A0DA-DBBEA58742EC

P2860

Q37202568-036487AF-7DA8-49E8-9880-30089C8C2947

Q37202568-0902FE9C-C946-4884-93FD-450369D89E85

Q37202568-0A781C55-BEF7-48AC-A61B-AAD70E6E2956

Q37202568-2029D349-CC13-42FD-99AC-A8FB0002E3FF

Q37202568-22D2F313-F5AC-4CA5-A283-522AABC779C2

Q37202568-23F5B728-84F7-4DD6-9975-2D33246C6EA5

Q37202568-2671A943-7EAC-47F1-8F0D-FE7F5FC6AEBC

Q37202568-27ACAE56-B5DE-4FC8-B34E-9FE6A59CD1C3

Q37202568-2BE8699A-AB7F-4170-96BB-A6DB3E25A33A

Q37202568-2EB854FB-0C59-4B14-9B1F-AF7B797B1728

P304

Q37202568-E448D648-9594-450E-8933-B0503F52E679

P31

Q37202568-04FD39DF-BF9E-410E-99CE-8573D15ECD53

P356

Q37202568-F452DA12-75A4-4E25-B0A1-D3E9E2516A12

P433

Q37202568-A38FE6AC-5D78-4160-976A-B9DB281F7CEF

P478

Q37202568-029FE4BD-C9E7-4713-A43E-D63A871B8DDE

P577

Q37202568-725A8F70-FC32-4136-A0F9-9B6C91BAA9B0

P698

Q37202568-39D482CE-225F-49EE-9619-1808A4270C37

P932

Q37202568-D70CF53E-365D-4A12-919D-74516E08E235

P356

P1433

DNA and Cell Biology

P1476

Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.

@en

P2093

Bo Li

http://www.w3.org/2001/XMLSchema#string

Haitao Zheng

http://www.w3.org/2001/XMLSchema#string

Lijian Yang

http://www.w3.org/2001/XMLSchema#string

Qi Shen

http://www.w3.org/2001/XMLSchema#string

Shaohua Chen

http://www.w3.org/2001/XMLSchema#string

Sichu Liu

http://www.w3.org/2001/XMLSchema#string

Xianfeng Zha

http://www.w3.org/2001/XMLSchema#string

Xiuli Wu

http://www.w3.org/2001/XMLSchema#string

Yangqiu Li

http://www.w3.org/2001/XMLSchema#string

Yu Chen

http://www.w3.org/2001/XMLSchema#string

P2860

A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55

ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ-PP2A

PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum

Wnt/beta-catenin signaling: components, mechanisms, and diseases

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Genomic organization and mapping of the gene encoding the PP2A B56gamma regulatory subunit

Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia

Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial.

P304

573-581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/DNA.2013.2138

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23941244

http://www.w3.org/2001/XMLSchema#string

P932

3785212

http://www.w3.org/2001/XMLSchema#string